Gastroenterology — MCQs
On this page
A 26-year-old man presents with intermittent cramping abdominal pain and low-volume diarrhea for 3 weeks. On physical examination, he is afebrile; there is mild lower abdominal tenderness but no masses, and bowel sounds are present. A stool sample is positive for occult blood. The symptoms subside within 1 week. Six months later, abdominal pain recurs with perianal pain. On physical examination, there is now a perirectal fistula. Colonoscopy shows many areas of mucosal edema and ulceration, and some areas that appear normal. Microscopic examination of a biopsy specimen from an ulcerated area shows a patchy acute and chronic inflammatory infiltrate, crypt abscesses, and noncaseating granulomas. Which of the following underlying disease processes best explains these findings?
Which of the following is NOT associated with Crohn's disease?
Dementia is a feature of which disease?
Non-alcoholic steatohepatitis is commonly seen in which of the following conditions?
A 29-year-old woman has recently developed milk intolerance. What is the most likely underlying condition?
Which of the following is NOT a complication of reflux esophagitis?
Reflux esophagitis is defined as the esophageal pH being less than which value?
What is the most common symptom of primary biliary cirrhosis?
Which of the following is the most unlikely feature of hepatocellular carcinoma?
What is the best test to diagnose gastroesophageal reflux disease and quantify acid output?
Gastroenterology Indian Medical PG Practice Questions and MCQs
Question 651: A 26-year-old man presents with intermittent cramping abdominal pain and low-volume diarrhea for 3 weeks. On physical examination, he is afebrile; there is mild lower abdominal tenderness but no masses, and bowel sounds are present. A stool sample is positive for occult blood. The symptoms subside within 1 week. Six months later, abdominal pain recurs with perianal pain. On physical examination, there is now a perirectal fistula. Colonoscopy shows many areas of mucosal edema and ulceration, and some areas that appear normal. Microscopic examination of a biopsy specimen from an ulcerated area shows a patchy acute and chronic inflammatory infiltrate, crypt abscesses, and noncaseating granulomas. Which of the following underlying disease processes best explains these findings?
- A. Amebiasis
- B. Crohn disease (Correct Answer)
- C. Sarcoidosis
- D. Shigellosis
Explanation: The clinical presentation and histopathology are classic for **Crohn Disease (CD)**. The key diagnostic features in this case include: 1. **Skip Lesions:** The colonoscopy shows "areas of mucosal edema and ulceration" interspersed with "areas that appear normal," which is the hallmark of CD [1]. 2. **Transmural Involvement & Fistulae:** The development of a perirectal fistula indicates inflammation extending through the entire bowel wall, a characteristic of CD (unlike Ulcerative Colitis, which is superficial) [1]. 3. **Noncaseating Granulomas:** This is a highly specific histological finding for Crohn disease (seen in ~35% of cases) and helps differentiate it from other forms of Inflammatory Bowel Disease (IBD). **Analysis of Incorrect Options:** * **Amebiasis:** Caused by *Entamoeba histolytica*, it typically presents with "flask-shaped" ulcers. While it can cause occult blood, it does not cause skip lesions, perianal fistulae, or noncaseating granulomas. * **Sarcoidosis:** While sarcoidosis is characterized by noncaseating granulomas, it rarely involves the gastrointestinal tract in isolation and does not typically present with skip lesions or perianal fistulae. * **Shigellosis:** This is an acute bacterial dysentery. It causes self-limiting, diffuse mucosal inflammation and does not lead to chronic recurring symptoms, fistulae, or granulomatous inflammation [1]. **NEET-PG High-Yield Pearls:** * **Distribution:** CD can affect any part of the GIT from "Mouth to Anus" (most common site is the terminal ileum) [1]. * **Morphology:** Look for "Cobblestone appearance," "Creeping fat," and "String sign of Kantor" on barium studies [1]. * **Smoking:** Smoking is a risk factor for Crohn Disease but is protective in Ulcerative Colitis. * **ASCA vs p-ANCA:** CD is often associated with **ASCA** (Anti-Saccharomyces cerevisiae antibodies), whereas UC is associated with **p-ANCA**.
Question 652: Which of the following is NOT associated with Crohn's disease?
- A. Skip lesions
- B. Fistula
- C. Toxic megacolon (Correct Answer)
- D. Transmural involvement
Explanation: **Explanation:** The correct answer is **C. Toxic megacolon**. **Why Toxic Megacolon is the correct answer:** Toxic megacolon is a life-threatening complication characterized by non-obstructive colonic dilatation (>6 cm) associated with systemic toxicity. While it can occur in any inflammatory process of the colon, there is a high risk of colonic perforation in these instances, though it is more classically associated with Ulcerative Colitis [1]. In Crohn’s disease, the characteristic **transmural fibrosis** and thickening of the bowel wall typically prevent the extreme dilatation seen in toxic megacolon. **Analysis of Incorrect Options:** * **A. Skip lesions:** This is a hallmark of Crohn’s disease. Unlike the continuous involvement seen in UC, Crohn’s presents with areas of diseased bowel interspersed with normal-appearing "skip" areas [1]. * **B. Fistula:** Because Crohn’s disease involves the entire thickness of the bowel wall (transmural), it frequently leads to the formation of sinus tracts that penetrate into adjacent organs or the skin, resulting in fistulae (e.g., perianal, enteroenteric, or enterovesical) [1]. Fistulae are considered specific to Crohn's disease [1]. * **D. Transmural involvement:** Crohn’s disease affects all layers of the gastrointestinal wall (mucosa to serosa). In contrast, Ulcerative Colitis is limited to the mucosa and submucosa. **NEET-PG High-Yield Pearls:** * **Smoking:** Increases the risk and severity of Crohn’s disease but is protective in Ulcerative Colitis. * **Granulomas:** Non-caseating granulomas are pathognomonic for Crohn’s (found in ~35% of cases). * **String Sign of Kantor:** A classic radiological finding in Crohn’s due to terminal ileal narrowing and ulceration [1]. * **ASCA vs. p-ANCA:** Crohn’s is associated with **ASCA** (Anti-Saccharomyces cerevisiae antibodies), while UC is associated with **p-ANCA**.
Question 653: Dementia is a feature of which disease?
- A. Whipple disease (Correct Answer)
- B. Celiac disease
- C. Tropical sprue
- D. Crohn disease
Explanation: **Explanation:** **Whipple Disease** is a rare systemic infectious disease caused by the gram-positive bacterium *Tropheryma whipplei*. It typically presents as a multi-system disorder. While malabsorption and weight loss are hallmark features, the involvement of the Central Nervous System (CNS) is a critical diagnostic clue. CNS manifestations occur in approximately 10–40% of cases and can include **dementia**, ophthalmoplegia, and myoclonus. A highly specific pathognomonic sign is **oculomasticatory myorhythmia** (pendular eye movements synchronized with jaw contractions). **Analysis of Incorrect Options:** * **Celiac Disease:** Primarily presents with malabsorption, dermatitis herpetiformis, and ataxia (gluten ataxia), but dementia is not a standard clinical feature. * **Tropical Sprue:** A chronic diarrheal illness seen in residents or visitors to the tropics; it leads to megaloblastic anemia (Vitamin B12/Folate deficiency) but does not cause primary dementia. * **Crohn Disease:** An inflammatory bowel disease (IBD) characterized by transmural inflammation and granulomas. Extraintestinal manifestations include uveitis, arthritis, and erythema nodosum, but not dementia. **High-Yield Clinical Pearls for NEET-PG:** * **Organism:** *Tropheryma whipplei* (PAS-positive macrophages in the lamina propria). * **Classic Tetrad:** Diarrhea/Malabsorption, Weight loss, Arthralgia (most common early symptom), and Lymphadenopathy. * **Biopsy:** Small intestinal biopsy shows "foamy macrophages" containing PAS-positive, acid-fast negative bacilli. * **Treatment:** Initial Ceftriaxone followed by oral Trimethoprim-sulfamethoxazole (TMP-SMX) for 1 year to cross the blood-brain barrier and prevent CNS relapse.
Question 654: Non-alcoholic steatohepatitis is commonly seen in which of the following conditions?
- A. Diabetes Mellitus
- B. Obesity (Correct Answer)
- C. Ischemic Heart Disease
- D. Gall stones
Explanation: **Explanation:** Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum ranging from simple steatosis to **Non-alcoholic Steatohepatitis (NASH)**, which involves inflammation and hepatocyte injury [1]. **Why Obesity is the Correct Answer:** Obesity is the most significant and strongest risk factor for NASH. The underlying pathophysiology involves **Insulin Resistance**, which leads to increased lipolysis in adipose tissue and a massive influx of free fatty acids to the liver [3]. This results in "lipotoxicity," oxidative stress, and the release of inflammatory cytokines (like TNF-α), triggering the progression from simple fat accumulation to steatohepatitis [2]. While NASH is a multi-systemic metabolic disorder, epidemiological data consistently show the highest prevalence among the morbidly obese (up to 90%). **Analysis of Incorrect Options:** * **A. Diabetes Mellitus:** While Type 2 DM is a major risk factor and frequently co-exists with NASH, obesity remains the primary driver and more common association in the general population [3]. * **C. Ischemic Heart Disease (IHD):** NASH is an independent risk factor for developing IHD (due to shared metabolic syndrome traits), but IHD itself does not cause NASH [1]. * **D. Gallstones:** There is an association between gallstones and NAFLD due to shared risk factors (obesity, rapid weight loss), but gallstones are a consequence of metabolic dysfunction rather than a cause or primary association of NASH. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver Biopsy (shows macrovesicular steatosis, Mallory-Denk bodies, and hepatocyte ballooning) [1]. * **First-line Management:** Weight loss (at least 7-10% of body weight) and lifestyle modification. * **Most Common Cause of Death:** Cardiovascular disease (not liver failure) [1]. * **Associated Syndrome:** Metabolic Syndrome (NASH is often considered the hepatic manifestation of Metabolic Syndrome).
Question 655: A 29-year-old woman has recently developed milk intolerance. What is the most likely underlying condition?
- A. celiac disease (Correct Answer)
- B. gastrinoma
- C. hyperthyroidism
- D. associated with skin pigmentation
Explanation: **Explanation:** The correct answer is **Celiac Disease**. **Why Celiac Disease is correct:** Celiac disease is an immune-mediated enteropathy triggered by gluten [1]. The primary pathology involves inflammatory damage to the small intestinal mucosa, leading to **villous atrophy**. The enzyme **lactase** is located at the very tips of the intestinal villi (the brush border). Because these tips are the first to be destroyed in Celiac disease, patients develop a **secondary lactase deficiency** [2]. This results in the clinical manifestation of milk intolerance (diarrhea, bloating, and flatulence after dairy consumption) alongside classic malabsorption symptoms [2]. **Analysis of Incorrect Options:** * **Gastrinoma (Zollinger-Ellison Syndrome):** While it causes diarrhea due to gastric acid hypersecretion and inactivation of pancreatic enzymes, it does not specifically cause milk intolerance via villous atrophy. * **Hyperthyroidism:** This causes increased gastrointestinal motility (hyperdefecation), but it is not a primary cause of carbohydrate malabsorption or milk intolerance. * **Associated with skin pigmentation:** This likely refers to **Whipple’s Disease** (which presents with hyperpigmentation, lymphadenopathy, and arthritis) [3]. While Whipple's causes malabsorption, Celiac disease is a much more common cause of adult-onset milk intolerance in clinical vignettes. **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** D2 (Distal Duodenal) biopsy showing Villous atrophy, Crypt hyperplasia, and increased Intraepithelial lymphocytes (Marsh Classification) [1]. * **Serology:** Anti-tissue Transglutaminase (anti-tTG) IgA is the screening test of choice. Anti-Endomysial Antibody (EMA) is the most specific. * **Dermatological Association:** Dermatitis Herpetiformis (itchy, vesicular rash on extensors). * **Secondary Lactose Intolerance:** Always consider Celiac disease or recent viral gastroenteritis (Rotavirus) when a patient presents with new-onset milk intolerance [2], [4].
Question 656: Which of the following is NOT a complication of reflux esophagitis?
- A. Stricture
- B. Schatzki's ring
- C. Barrett's esophagus
- D. Achalasia cardia (Correct Answer)
Explanation: The correct answer is **D. Achalasia cardia**. **Why Achalasia cardia is the correct answer:** Achalasia cardia is a **primary motility disorder** characterized by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of esophageal peristaltis. It is an **etiology** that can lead to symptoms like dysphagia, but it is not a complication of Gastroesophageal Reflux Disease (GERD). In fact, the pathophysiology is opposite: GERD involves a "leaky" or hypotonic LES, whereas Achalasia involves a hypertensive LES that fails to open. **Why the other options are incorrect:** * **A. Stricture:** Chronic acid exposure leads to inflammation and fibrosis of the esophageal wall [1]. Over time, this healing by scarring causes luminal narrowing (peptic stricture), a classic complication of long-standing GERD [1]. * **B. Schatzki’s ring:** This is a mucosal ring found at the squamocolumnar junction. While its exact etiology is debated, it is strongly associated with GERD and hiatal hernias; chronic acid irritation is a primary trigger for its formation. * **C. Barrett’s esophagus:** This is a premalignant condition where the normal stratified squamous epithelium is replaced by specialized columnar epithelium (metaplasia) due to chronic acid reflux [2]. It significantly increases the risk of esophageal adenocarcinoma [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Barrett’s Esophagus:** Requires endoscopic biopsy showing intestinal metaplasia (Goblet cells). * **Schatzki’s Ring:** Typically presents with "steakhouse syndrome" (intermittent dysphagia to solids, especially meat). * **Achalasia Diagnosis:** Gold standard is **Esophageal Manometry** (showing incomplete LES relaxation and aperistalsis). Barium swallow shows the characteristic **"Bird’s beak" appearance.** * **Complication Sequence:** GERD → Esophagitis → Stricture/Barrett’s → Adenocarcinoma [1],[2].
Question 657: Reflux esophagitis is defined as the esophageal pH being less than which value?
- A. 1
- B. 2
- C. 3
- D. 4 (Correct Answer)
Explanation: **Explanation:** The diagnosis of Gastroesophageal Reflux Disease (GERD) via 24-hour ambulatory pH monitoring is based on the **"Rule of 4."** Reflux esophagitis is defined as a drop in esophageal pH to **less than 4**. **Why 4 is the threshold:** The esophageal mucosa is physiologically sensitive to acid [1]. While the stomach maintains a very low pH, the esophagus typically maintains a neutral pH. Clinical studies and the **DeMeester Scoring system** have established that a pH < 4 is the critical threshold where pepsin becomes activated and the esophageal epithelium begins to undergo damage (acid injury). Monitoring the "Time pH < 4" (Total Acid Exposure Time) is the most reliable parameter for diagnosing pathological reflux [1]. **Analysis of Incorrect Options:** * **Options A (1) and B (2):** These represent extreme acidity levels typically found in the gastric lumen. While these values certainly cause damage, they are too restrictive for a diagnostic threshold; many patients suffer significant esophagitis at a pH of 3 or 3.5. * **Option C (3):** While acidic, a threshold of 3 would miss a significant number of reflux episodes that occur between pH 3 and 4, leading to a high false-negative rate. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** 24-hour ambulatory pH monitoring is the gold standard for diagnosing GERD, especially in patients with persistent symptoms despite PPI therapy and normal endoscopy. * **DeMeester Score:** A composite score used to quantify reflux; a score **>14.72** is considered abnormal. * **Bravo Capsule:** A wireless pH monitoring system that allows for 48–96 hours of data collection, offering better patient tolerance than the transnasal catheter. * **Impedance Testing:** Often combined with pH monitoring to detect **non-acid (weakly alkaline) reflux**, which pH monitoring alone might miss.
Question 658: What is the most common symptom of primary biliary cirrhosis?
- A. Pruritus (Correct Answer)
- B. Abdominal pain
- C. Jaundice
- D. Bleeding
Explanation: **Explanation:** Primary Biliary Cholangitis (PBC), formerly known as Primary Biliary Cirrhosis, is a chronic autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts [1]. **Why Pruritus is the correct answer:** **Pruritus (itching)** is the most common presenting symptom of PBC, occurring in approximately 50–70% of patients [1]. It often precedes jaundice by months or years [1]. The exact pathogenesis is complex but is attributed to the systemic accumulation of pruritogens (such as bile acids, endogenous opioids, or lysophosphatidic acid) due to impaired bile flow (cholestasis). It is typically worse at night and in warm weather [1]. Notably, **fatigue** is also a very frequent early symptom, often co-existing with pruritus [1]. **Why other options are incorrect:** * **Abdominal pain:** While some patients may experience vague right upper quadrant discomfort, it is not a hallmark or the most common presenting feature [1]. * **Jaundice:** This is a late-stage finding in PBC [1]. Its appearance usually signifies advanced ductal destruction and carries a poor prognostic implication. * **Bleeding:** Variceal bleeding or easy bruising (due to Vitamin K malabsorption) occurs only in the advanced cirrhotic stage of the disease. **NEET-PG High-Yield Pearls:** * **Demographics:** Classically affects middle-aged women (9:1 female-to-male ratio) [1]. * **Diagnostic Marker:** **Anti-Mitochondrial Antibody (AMA)** is the hallmark (positive in >95% of cases) [1]. * **Biochemical Profile:** Characterized by a disproportionate rise in **Alkaline Phosphatase (ALP)** and GGT compared to aminotransferases. * **Associated Conditions:** Frequently associated with other autoimmune diseases like Sjögren’s syndrome, Hashimoto’s thyroiditis, and Scleroderma (CREST) [1]. * **Treatment of choice:** **Ursodeoxycholic acid (UDCA)**, which slows disease progression. For pruritus, Cholestyramine is the first-line treatment.
Question 659: Which of the following is the most unlikely feature of hepatocellular carcinoma?
- A. Hepatomegaly
- B. Raised alpha-fetoprotein levels
- C. Raised alkaline phosphatase
- D. Jaundice (Correct Answer)
Explanation: **Explanation:** The correct answer is **Jaundice**. While jaundice can occur in Hepatocellular Carcinoma (HCC), it is typically a **late-stage manifestation** or a result of underlying end-stage cirrhosis rather than a primary presenting feature of the tumor itself. In the early to mid-stages of HCC, the remaining functional liver parenchyma is usually sufficient to conjugate and excrete bilirubin, making jaundice an "unlikely" or infrequent early finding compared to the other options. **Analysis of Options:** * **Hepatomegaly (Option A):** This is the most common physical finding in HCC. The rapid expansion of malignant cells leads to a palpable, often firm or nodular, enlargement of the liver [1]. * **Raised Alpha-fetoprotein (AFP) (Option B):** AFP is the classic tumor marker for HCC. Levels >400 ng/mL are highly suggestive of HCC in the presence of a liver mass, though it can be elevated in smaller amounts in chronic hepatitis [1]. * **Raised Alkaline Phosphatase (ALP) (Option C):** ALP is frequently elevated in HCC due to the "space-occupying" nature of the tumor causing localized intrahepatic bile duct compression or as part of the paraneoplastic response. **Clinical Pearls for NEET-PG:** * **Most common presentation:** Abdominal pain and hepatomegaly. * **Auscultation:** A hepatic bruit or friction rub over the liver is a high-yield, specific sign for HCC. * **Metastasis:** The most common site of extrahepatic spread is the **Lungs**. * **Triad:** The classic (though rare) presentation includes right upper quadrant pain, weight loss, and a palpable mass. * **Screening:** Patients with cirrhosis should be screened every 6 months using **Ultrasound + AFP** [1].
Question 660: What is the best test to diagnose gastroesophageal reflux disease and quantify acid output?
- A. Esophagram
- B. Endoscopy
- C. Manometry
- D. 24-hour pH monitoring (Correct Answer)
Explanation: **Explanation:** **24-hour pH monitoring** is considered the **gold standard** for diagnosing Gastroesophageal Reflux Disease (GERD). Its primary value lies in its ability to provide a definitive objective measurement of esophageal acid exposure. It calculates the **DeMeester Score**, which incorporates parameters like the total time pH is <4, the number of reflux episodes, and the duration of the longest episode. This test is specifically indicated for patients with persistent symptoms despite PPI therapy or those being evaluated for anti-reflux surgery (Nissen Fundoplication). **Why other options are incorrect:** * **Esophagram (Barium Swallow):** While useful for identifying anatomical abnormalities like hiatal hernia or strictures, it has very low sensitivity for diagnosing GERD itself. * **Endoscopy (EGD):** This is the first-line investigation to look for complications (esophagitis, Barrett’s esophagus, or malignancy). However, up to 60-70% of GERD patients have **Non-Erosive Reflux Disease (NERD)**, where the endoscopy appears completely normal. * **Manometry:** This is used to assess esophageal motility (e.g., diagnosing Achalasia) and to locate the Lower Esophageal Sphincter (LES) before placing a pH probe. It does not diagnose or quantify acid reflux. **Clinical Pearls for NEET-PG:** * **First-line investigation:** Upper GI Endoscopy (to rule out "red flags"). * **Gold Standard:** 24-hour ambulatory pH monitoring. * **Bravo pH Monitoring:** A wireless capsule version that allows for longer monitoring (48-96 hours) and is better tolerated by patients. * **Impedance-pH monitoring:** The best test to detect **non-acid (alkaline) reflux**.
Practice by Chapter
Esophageal Disorders
Practice Questions
Peptic Ulcer Disease
Practice Questions
Inflammatory Bowel Disease
Practice Questions
Irritable Bowel Syndrome
Practice Questions
Malabsorption Syndromes
Practice Questions
Pancreatitis (Acute and Chronic)
Practice Questions
Gastrointestinal Bleeding
Practice Questions
Liver Diseases and Cirrhosis
Practice Questions
Viral Hepatitis
Practice Questions
Biliary Tract Disorders
Practice Questions
Gastrointestinal Motility Disorders
Practice Questions
Gastrointestinal Malignancies
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free